Foolish calculations on both. IMO I will trust 3
Post# of 30028
(Total Views: 479)
Posted On: 05/22/2018 2:09:01 PM
Foolish calculations on both. IMO
I will trust 3rd party valuations at a Robust 9 figures for 1 indication alone in the US & Europe.
GC is leading the helm.
AMBS and all the subs will succeed because of him, period.
Can't have it both ways.
Live Life With Aloha
"Based upon an independent 3rd party valuation of the PD-LID indication in the US and Europe alone, Eltoprazine is the most valuable asset in the Amarantus portfolio as measured by risk-adjusted net present value (rNPV), with a robust 9-figure valuation."
https://ir.amarantus.com/press-releases/detai...s-overview
I will trust 3rd party valuations at a Robust 9 figures for 1 indication alone in the US & Europe.
GC is leading the helm.
AMBS and all the subs will succeed because of him, period.
Can't have it both ways.
Live Life With Aloha
"Based upon an independent 3rd party valuation of the PD-LID indication in the US and Europe alone, Eltoprazine is the most valuable asset in the Amarantus portfolio as measured by risk-adjusted net present value (rNPV), with a robust 9-figure valuation."
https://ir.amarantus.com/press-releases/detai...s-overview
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼